GLENMARK:NSE
Glenmark Pharmaceuticals Ltd
₹2,334.00
arrow_downward
-0.03%(-0.70) 1H
1 Okt, 3:30:00 PTG GMT+5:30 · INR
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk GLENMARK...
Buka
₹2,339.00
Tinggi
₹2,360.00
Rendah
₹2,279.30
Permodalan Pasaran
657.87B
Purata volum
578.61K
Volum
972.52K
Dividen
0.21%
Dividen suku tahunan
₹1.25
Tarikh tanpa dividen
3 Okt 2025
Nisbah H/P
36.65
tgi 52 mgu
₹2,537.60
rdh 52 mgu
₹1,792.60
EPS
₹63.68
Syer tertunggak
0.00
Bilangan pekerja
17K
Buka
₹2,339.00
Tinggi
₹2,360.00
Rendah
₹2,279.30
Permodalan Pasaran
657.87B
Purata volum
578.61K
Volum
972.52K
Dividen
0.21%
Dividen suku tahunan
₹1.25
Tarikh tanpa dividen
3 Okt 2025
Nisbah H/P
36.65
tgi 52 mgu
₹2,537.60
rdh 52 mgu
₹1,792.60
EPS
₹63.68
Syer tertunggak
0.00
Bilangan pekerja
17K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Stock Titan
·
1 jam lalu
Five Singapore clinics focus on foot care; two on women's wellness. Cuprina has agreed to acquire them.
GlobeNewswire
·
1 jam lalu
ATA Creativity Global Announces Receipt of a Bid Deficiency Notice from Nasdaq
Profil
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
Perihal Glenmark Pharmaceuticals Ltd